Valeant International Bermuda

Bermudes

 
Quantité totale PI 5
Rang # Quantité totale PI 309 305
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 659 438
Parent Valeant Pharmaceuticals International, Inc.
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

2 0
2 1
0 0
0
 
Dernier brevet 2014 - Bupropion hydrobromide polymorphs
Premier brevet 1992 - Biodegradable controlled release...
Dernière marque 1994 - FLASH DOSE
Première marque 1994 - FLASH DOSE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2013 Invention Pharmaceutical compositions. The present invention provides for a pharmaceutical composition tha...
Invention Bupropion hydrobromide polymorphs. Polymorphous and amorphous forms of bupropion hydrobromide ar...
2012 Invention Bupropion hydrobromide polymorphs. Polymorphous and amorphous forms of bupropion hydrobromide are...
2009 Invention Rapidly dissolving vitamin formulation and methods of using the same. Rapidly dissolvable nutriti...
Invention Controlled release formulations using intelligent polymers. A controlled release pharmaceutical c...
2008 Invention Bupropion hydrobromide and therapeutic applications. Bupropion hydrobromide formulations as well ...
2007 Invention Multiparticulate osmotic delivery system. The invention relates to a pharmaceutical composition, ...
Invention Modified release formulations of a bupropion salt. The present invention relates to pharmaceutica...
2006 Invention Modified-release formulations of a bupropion salt. The present invention relates to pharmaceutica...
2003 Invention Modified release formulations of at least one form of tramadol. The present invention provides fo...
Invention Controlled release dosage forms. The invention provides stable controlled release monolithic coat...
2002 Invention Modified release formulations of selective serotonin re-uptake inhibitors. A modified release pha...
Invention Extended release pharmaceutical tablet of metformin. The invention provides an extended release p...
Invention Use of colesevelam in reducing serum glucose. A method for treating hyperglycemia and/or reducing...
2001 Invention Sustained-release microgranules containing diltiazem as active principle. Novel forms of sustaine...
1999 Invention Method and apparatus for forming an encapsulated product matrix. A method and apparatus provides ...
Invention Storage stable amoxycillin and clavulanate suspension composition. A dry powder formulation of an...
1998 Invention Pharmaceutical composition containing bupropion hydrochloride and a stabilizer. Novel, stable for...
Invention Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer. N...
Invention Sustained-release microgranules containing diltiazem as the active principle. Novel forms of sust...
Invention Sachet formulations. Bioaffecting sachets, or powders, containing coated liquiflash microspheres ...
Invention Dosage forms containing taste masked active agents. The invention relates to compositions useful ...
Invention Process and apparatus for producing shearform matrix material. The present invention is a unique ...
Invention System for rendering substantially non-dissoluble bio-affecting agents bio-available. The present...
Invention Fatty ester combinations. The thermoforming of compositions containing active agents is carried o...
Invention Fast-dissolving comestible units formed under high-speed/high-pressure conditions. The invention ...
Invention Controlled release compositions and methods for the treatment of hyperlipidemia. Lipid lowering d...
Invention Product and method for the treatment of hyperlipidemia. Lipid lowering dosage units, to be used o...
Invention Apparatus for melt spinning feedstock material. A spinner head provides for the production of mel...
Invention Self-binding shearform compositions. A self-binding, glycerine-free tablettable composition has a...
Invention Controlled release formulations using intelligent polymers. An extended release dosage compositio...
Invention Saccharide-based matrix. The present invention is a saccharide-bsed matrix and the product result...
1997 Invention Drug delivery systems utilizing liquid crystal structures. Vitamin E TPGS/drug compositions and m...
Invention Immediate release dosage forms containing microspheres. The invention deals with microspheres whi...
Invention Self-binding shearform compositions. Shearform compositions made without added glycerine are disc...
Invention Method of preparing mesomorphic sugar products. The present invention is a new mesomorphic polycr...
Invention Spinner head having flow restricting inserts. A spinner head is used for spinning and processing ...
Invention Apparatus for melt spinning feedstock material having a flow restricting ring. A spinner head pro...
1996 Invention Apparatus and process for strengthening low density compression dosage units and product therefro...
Invention Delivery of controlled-release system(s). The present invention is a method and a dosage unit for...
Invention Process and apparatus for making rapidly dissolving dosage units and product therefrom. The prese...
Invention Method of preparing a dosage unit by direct tableting and product therefrom. The present inventio...
1995 Invention Saccharide-based matrix. The present invention is a saccharide-based matrix, and the products res...
1994 Invention Liquiflash particles and method of making same. The present invention is a method of making discr...
P/S Rapidly dissolving matrix preparations for the delivery of medicinal active ingredients for the t...